Abstract: Diabetes mellitus (DM) and obesity are believed to be risk factors for colorectal cancer in humans. In experiment 1, male nondiabetic Long-Evans Tokushima Otsuka (LETO) rats and Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model animal of type 2 DM, were whole-body X-irradiated (4 Gy) at 6 and 8 weeks of age and euthanized at 78 weeks of age (n=15, respectively). The incidences of small intestine adenocarcinoma in LETO and OLETF rats were 0% and 30%, respectively. In experiment 2, male LETO and OLETF rats (n=24, respectively) were given s.c. injections of 15 mg/kg azoxymethane (AOM) once weekly for 3 weeks and euthanized at 36 weeks of age. The incidences of Zymbal gland tumors in LETO and OLETF rats were 0% and 67%, respectively (P<0.001), whereas those of small intestine adenocarcinoma were 0% and 43% (P<0.001) and those of cecum/colon adenocarcinoma were 46% and 79% (P<0.05), respectively. Fatty change of hepatocytes was common in OLETF rats (63%) but not in LETO rats. Serum triglyceride and free fatty acid levels in OLETF rats were significantly higher than in LETO rats at sacrifice, whereas serum insulin levels in OLETF rats were very diverse. These data suggest that hyperlipidemia plays a significant role in high susceptibility to lower intestinal tract carcinogenesis in OLETF rats; this strain is susceptible to AOM-induced Zymbal gland carcinogenesis.
Introduction
Epidemiologic studies have suggested a positive link between diabetes mellitus (DM) and various neoplasms including colon cancer 1, 2 . Obesity is a risk factor for DM and cancer of various organs including the colon 3, 4 . Insulin resistance, chronic inflammation and/or altered adipokine secretion with resultant hyperlipidemia may be involved in DM and obesity-related cancer 5 . Exogenous insulin use may also be a risk factor for colorectal cancer 6 .
Otsuka Long-Evans Tokushima Fatty (OLETF) rats 7 , established from a closed colony of Long-Evans rats by selective breeding along with nondiabetic Long-Evans Tokushima Otsuka (LETO) rats, are a model animal of type 2 DM and show late conversion to insulin-dependent disease. This strain has mild obesity, and a homozygous deletion in cholecystokinin-1 (CCK1) receptor gene responsible for hyperphagia has been identified 8, 9 . OLETF rats are susceptible to N-nitrosobis (2-oxopropyl) amine-induced thyroid carcinogenesis 10 . In the present study, we examined X-irradiation and azoxymethane (AOM)-induced carcinogenesis in LETO and OLETF rats.
Materials and Methods

Animals
LETO and OLETF rats were obtained from Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan. Animals were housed three to a plastic cage with sterilized woodchips for bedding in an air-conditioned room at 23 ± 2 °C and 55 ± 10% humidity with a 12-h light/dark cycle and given pellet diet (Oriental MF; Oriental Yeast Co., Ltd., Tokyo, Japan) and tap water ad libitum. Experiments were conducted according to the Guidelines for the Care and Use of Laborato-ry Animals of the University of Tokushima, and the experimental protocol was approved by the Animal Committee.
Carcinogenicity study
Experiment 1: After a 1-week acclimation period, sixweek-old male LETO and OLETF rats (n=15, respectively) were whole-body X-irradiated (4 Gy) at 6 and 8 weeks of age ( Fig. 1) . Three animals were put into an acrylic resin box and irradiated at a dose rate of 1.54 Gy/min using an X-ray irradiation system (Hitachi MBR-1520R-3; Hitachi Medical Corporation, Tokyo, Japan). Control animals (n=15, respectively) were maintained for approximately 2 min in the chamber without irradiation (sham-irradiated). Body weight was monitored every other week, and all animals were euthanized at 78 weeks of age under carbon dioxide narcosis. The stomach and intestine were opened, and the size and location of tumors were recorded; the tumors were then fixed in 10% buffered formalin and embedded in paraffin. For histological examination, tissue sections were stained with hematoxylin and eosin. Other major organs were also examined histologically. At 12 and 42 weeks of age, control rats were submitted to an oral glucose tolerance test (OGTT) after 16-h fasting in experiment 1 (n=9). Glucose (Wako Pure Chemical Industries, Ltd., Osaka, Japan) was given by gavage, 2 g/kg body weight, at about 10 a.m. Blood was collected from the tail. Thirty-minute postglucose load blood glucose was measured by the glucose oxidase method. Serum insulin was measured using an ELISA kit (Morinaga Institute of Biological Science, Yokohama, Japan). Experiment 2: AOM was purchased from Wako Pure Chemical Industries, Ltd. Six-week-old male LETO and OLETF rats (n=24, respectively) were given s.c. injections of AOM at a dose of 15 mg/kg body weight once weekly for 3 weeks (Fig. 1) . AOM was dissolved in 0.9% NaCl just before use. Animals were euthanized at 36 weeks of age. Blood samples were collected from the inferior vena cava at sacrifice (n=9, respectively), and the serum to examine insulin, triglyceride, free fatty acid and total cholesterol was frozen at -30 °C until use. Serum lipids were measured by SRL Inc., Tokyo, Japan. Histological examination of organs including neoplasms was performed.
Quantitative real-time RT-PCR
Livers from untreated 24-week-old male LETO and OLETF rats (n=5, respectively) were stabilized with RNAlater (Applied Biosystems, Carlsbad, CA, USA) at 4 °C overnight and then total RNAs were isolated using an RNeasy ® Mini Kit (QIAGEN, Valencia, CA, USA). By using 1-µg aliquots, cDNAs were synthesized with SuperScript II reverse transcriptase and random hexamers (Invitrogen, Carlsbad, CA, USA). Reactions were conducted at 42 °C for 60 min, and then the temperature was increased to 72 °C for 15 min. The total cDNAs were then subjected to quantitative real-time RT-PCR (qRT-PCR) by the comparative Ct method. Each sample was mixed with SYBR Premix Ex Taq II (Takara Bio, Shiga, Japan) and specific primers for insulin-like growth factor (IGF)-1, plasminogen activator inhibitor (Pai)-1 and β-actin, according to the manufacturer's guidelines. β-Actin was used as an internal standard. These samples were then amplified using a 7500 Real-time PCR System (Applied Biosystems), and the data were analyzed with 7500 System SDS software (Applied Biosystems). Thermocycling program was as follows: 95 °C for 30 s for initial denaturation and 40 cycles of 95 °C for 5 s and 60 °C for 34 s for amplification. The sequences of the primers were as follows: IGF-1-F, 5′-TTCAGTTCGTGTGTGGAC-CAAG-3′; IGF-1-R, 5′-GATCACAGCTCCGGAAGCAA-3′; Pai-1-F, 5′-GCCCAGCATTCAGCCTTTG-3′; Pai-1-R, 5′-AAGACTTTGCTGAGTGAAGGCGTAG-3′; β-actin-F, 5′-GGAGATTACTGCCCTGGCTCCTA-3′; and β-actin-R, 5′-GACTCATCGTACTCCTGCTTGCTG-3′.
Measurement of food intake
Male LETO and OLETF rats were given pellet diet, and food intake and body weight were monitored every other week until 20 weeks of age (n=15, respectively).
Statistical analyses
The incidence of tumors was analyzed by Fisher's exact probability test; other data were analyzed by two-tailed Student's t-test.
Results
Experiment 1
The Average body weight of X-irradiated OLETF rats was found to be increased at sacrifice because of huge soft tissue sarcomas in some rats (Fig. 2) . X-irradiation increased the incidence of various tumors in both strains (Table 1) . Small intestinal adenocarcinomas developed in 3 OLETF rats (30%), but not in LETO rats. The colonic tumor in the X-irradiated OLETF rat was a leiomyosarcoma. X-irradiation caused a low incidence of islet cell tumors in both strains. Hyperglycemia at 12 and 42 weeks of age and hyperinsulinemia at 42 weeks of age were observed in control OLETF rats (Fig. 3) . X-irradiation increased blood glucose levels and reduced insulin levels in OLETF rats compared with the control at 42 weeks of age, although not significantly, whereas these parameters were not affected by X-irradiation in LETO rats.
Experiment 2
The average body weight of OLETF rats was higher than that of LETO rats throughout the experimental period (Fig. 4) . The incidence of Zymbal gland, small intestine and colon tumors in OLETF rats was significantly higher than in LETO rats (Table 2) . Malignant lymphoma developed in one LETO rat, but no other tumors developed in either strain. The average numbers of small intestine and colon tumors in OLETF rats were higher than in LETO rats (Fig. 5) . These tumors were mainly tubular adenocarcinoma histologically, and signet-ring cell carcinoma developed in one LETO rat. In one OLETF rat, colonic cancer metastasized to a retroperitoneal lymph node. Six of the 16 Zymbal gland tumors in OLETF rats, sebaceous carcinoma histologically, were bilateral (Fig. 6 ). The incidence of fatty change of hepatocytes was 15/24 (63%) in OLETF rats and 0% in LETO rats (Fig.  7) . Pancreatic islets of OLETF rats showed hemosiderosis, loss of islet cells and fibrosis. The average serum insulin level in OLETF rats was lower than in LETO rats (Fig. 8) .
The insulin levels in 2 of 9 OLETF rats were higher than the maximum value in LETO rats, but those in 5 OLETF rats were lower than the minimum value in LETO rats. Serum triglyceride and free fatty acid levels in OLETF rats were significantly higher than in LETO rats at sacrifice.
Analysis of the liver
The relative expression levels of liver IGF-1 and Pai-1 mRNA in OLETF rats were 1.08 ± 0.23-fold and 1.63 ± 0.45- Fig. 8 . Serum insulin, triglyceride, free fatty acid and total cholesterol in LETO and OLETF rats at 36 weeks of age (experiment 2). * and **; P < 0.05 and P < 0.01, respectively, versus LETO rats (two-tailed Student's t-test). A, insulin; B, triglyceride; C, free fatty acid; D, total cholesterol. □, LETO rat; ■, OLETF rat; Bars, SD. fold, respectively, those in LETO rats. No significant differences were observed between the strains (Fig. 9) .
Food intake
The average food intakes of the untreated LETO and OLETF rats were 18.5 g and 26.0 g, respectively. The food intake/body weight ratio in OLETF rats was 1.08-1.19 times higher than in LETO rats (Fig. 10) .
Discussion
X-irradiation induced a low incidence of intestinal cancer in OLETF rats, but not in LETO rats, and OLETF rats were clearly susceptible to AOM-induced Zymbal gland and lower intestinal tract carcinogenesis. Zucker obese rats, a model animal with leptin receptor gene mutation with hyperleptinemia, exhibit marked obesity and type 2 DM 11, 12 . Zucker obese rats are also more susceptible to AOM-induced colon cancer than control Zucker lean rats 13, 14 [REMOVED HYPERLINK FIELD] . The OLETF strain also shows hyperleptinemia, but there is no mutation in the leptin receptor gene 15 , and obesity is milder than in Zucker obese rats.
Hyperlipidemia is suggested to be an important factor for intestinal polyp formation in Apc-deficient mice from studies on suppression of hyperlipidemia by peroxisome proliferator-activated receptor-α and receptor-γ agonists and by Pai-1 blockers 16, 17 . In our recent study, 20% caloric restriction reduced serum triglyceride and inhibited both AOM-induced colonic and Zymbal gland neoplasms in OLETF rats (data not shown). Hence, the hyperlipidemic state in OLETF rats may play a significant role in high susceptibility to intestinal carcinogenesis. Insulin and IGF-1, growth factors in vitro, increase in obesity. It is reported that insulin promoted AOM-induced colon carcinogenesis in F344 rats 18 . In the present experiments, the insulin levels in OLETF rats were diverse, and the hepatic IGF-1 mRNA level in OLETF rats was not different from that in LETO rats, suggesting that the role of hyperinsulinemia in carcinogenesis is not distinct. However, the role of insulin and the molecular mechanisms of adipose tissue dysfunction should be further investigated 4, 5 .
The data for the insulin levels in the OGTT in experiment 1 and those without glucose load in experiment 2 were various. Although the measurement conditions were different, AOM treatment might reduce insulin levels.
The Zymbal gland, a sebaceous gland of the external ear canal, is a target organ of AOM in rats 19, 20 . In the present study, Zymbal gland tumor developed at a high rate, 67% in AOM-treated OLETF rats. However, in our recent study performed using the same protocol as the present study in nonobese Long-Evans Agouti rats 21 , a new model of type 2 DM, the incidences of Zymbal gland, small intestine and colon tumors were 0%, 4% and 83%, respectively (unpublished data). There is no description of Zymbal gland tumor in AOM-treated Zucker obese rats 14 . Therefore, the OLETF rat should be a strain susceptible to AOM-induced Zymbal gland carcinogenesis. It is known that both Zymbal glands and intestines in rats are target organs of heterocyclic amines in cooked foods such as 2-amino-3-methylimidazo [4,5- 22 . In humans, the familial disease of sebaceous carcinoma plus visceral cancer including colorectal carcinoma is known as Muir-Torre syndrome 23 , a variant of hereditary nonpolyposis colorectal cancer. The mechanism of susceptibility to Zymbal gland carcinogenesis in OLETF rats should be elucidated.
In conclusion, the hyperphagic OLETF strain is a useful model for investigation of mechanisms of carcinogenesis and cancer prevention in diabetic conditions and obesity, and hyperlipidemia may play an important role in high susceptibility to Zymbal gland and intestinal carcinogenesis in OLETF rats.
